DCN and recessive dystrophic epidermolysis bullosa: Subsequently, experimental pre-clinical support for the abilities of decorin to modify RDEB severity was obtained from systemic overexpression of decorin in collagen VII hypomorphic mice (Cianfarani et al., 2019).